Study finds 'unbridled rise in cost' of MS treatments is hitting patients hardest
New versions of best-selling drugs from Pfizer, Lilly and BMS have been given a positive opinion from the European regulator
European regulator gives the OK as a standalone treatment for melanoma
British firm partners with Celgene, Innate and Juno following Q1 revenue hike
Two sides – the European pharma trade body EFPIA and the medical aid charity MSF – argue their views on the price of Gilead's Sovaldi.